Ocuphire Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2004
Net Income	-9.99	17.89	-56.69	-24.62	-6.17	-14.37	-25.29	-9.31	-14.38	-18.52	Upgrade
Depreciation & Amortization	0.01	0	0	0.01	0	0.05	0.04	0.03	0.03	0.03	Upgrade
Share-Based Compensation	3.51	1.81	1.91	1.51	0.31	1.25	1.08	1.51	1.14	1.02	Upgrade
Other Operating Activities	5.36	-5.39	35.41	16.31	2.27	-5.77	8.76	-5.46	-4.13	6.43	Upgrade
Operating Cash Flow	-1.11	14.31	-19.37	-6.8	-3.59	-18.84	-15.42	-13.23	-17.35	-11.04	Upgrade
Capital Expenditures	0	0	0	0	-0.03	-0.04	-0.08	-0.01	-0.06	-0.04	Upgrade
Acquisitions	0	0	-0.1	0.54	0	0	0	0	0	0	Upgrade
Change in Investments	0	0	0	0	0	11.95	-9.3	4.49	9.62	-22.82	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	-	-	0.2	Upgrade
Investing Cash Flow	0	0	-0.1	0.54	-0.03	11.91	-9.37	4.48	9.55	-22.66	Upgrade
Share Issuance / Repurchase	8.98	4.32	27.07	0.06	0	6.87	22.11	10.12	8.17	24.84	Upgrade
Debt Issued / Paid	0	-0.54	0.54	23.35	4.7	0	0	0	0	0	Upgrade
Other Financing Activities	-	-	-	-2.29	-	-0.1	-	-	-	-	Upgrade
Financing Cash Flow	8.98	3.79	27.61	21.12	4.7	6.77	22.11	10.12	8.17	24.84	Upgrade
Net Cash Flow	7.87	18.1	8.14	14.86	1.09	-0.15	-2.68	1.38	0.37	-8.86	Upgrade
Free Cash Flow	-1.11	14.31	-19.37	-6.8	-3.62	-18.88	-15.5	-13.24	-17.41	-11.08	Upgrade
Free Cash Flow Margin	-5.84%	35.92%	-3288.62%	-	-	-	-	-	-	-	Upgrade
Free Cash Flow Per Share	-0.05	0.72	-1.30	-1.46	-1.27	-27.57	-27.15	-29.22	-45.83	-30.21	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).